Search results for: 'biologics drug product'
- Related search terms
- Product and Pipeline Analysis of the Global Therapeutic Lipid Modulators Market
- biologics contract development ar manufacturing market forecast to 2024
- biologics contract development app manufacturing market forecast to 2024
- biologics contract development ar manufacturing market forecast to 2014
- biologics contract development ar manufacturing market forecast to 2025
-
25 Jul 2016  |  Europe  |  Market Research
Analysis of the Global Biologics API Market
Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies
This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose dis...
$3,000.00
Special Price $2,250.00 save 25 %
-
19 Feb 2024  |  Global  |  Market Research
Innovations in Small Molecule Drug Delivery and Formulation
Disruptive Technologies Drive Growth Opportunities for New Product Launches
Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
18 May 2026  |  Global  |  Frost Radar
Frost Radar™: Smart Delivery Formulations for Biologics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...
$4,950.00 -
17 Jul 2023  |  Global  |  Market Research
Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028
Collaborations with Innovative Platform Developers will Drive Growth Potential
This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC comprises multiple components such as the antibody, conjugation chemistry, linker, and payload. Many companies are working on each component while others only develop ADCs, which makes the market highly competitive. The development...
$2,450.00
Special Price $1,837.50 save 25 %
-
05 Sep 2022  |  Global  |  Technology Research
Technology Growth Opportunities for Exosome-Mediated Drug Delivery
Exosomes Are Promising Delivery Carriers for Advanced Therapeutics
Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Sep 2024  |  Global  |  Technology Research
AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029
AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.
This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...
$4,950.00
Special Price $4,207.50 save 15 %
-
21 Dec 2022  |  Global  |  Technology Research
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Nov 2022  |  Global  |  Technology Research
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Strategic partnering and new product development will enable better biologics for personalized and targeted treatment
Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Sep 2025  |  Global  |  Technology Research
Recent Advances in Biologics, Regenerative Medicine and Radiotherapies
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...
$950.00